AGRX - Agile Therapeutics GAAP EPS of -$0.53 misses by $0.23 revenue of $3M beats by $0.67M
- Agile Therapeutics press release ( NASDAQ: AGRX ): Q3 GAAP EPS of -$0.53 misses by $0.23 .
- Revenue of $3M (+132.6% Y/Y) beats by $0.67M .
For further details see:
Agile Therapeutics GAAP EPS of -$0.53 misses by $0.23, revenue of $3M beats by $0.67M